Elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia.
Published
Journal Article (Letter)
Full Text
Duke Authors
Cited Authors
- Giles, F; Rizzieri, D; Ravandi, F; Swords, R; Jacobsen, TF; O'Brien, S
Published Date
- April 2012
Published In
Volume / Issue
- 36 / 4
Start / End Page
- e71 - e73
PubMed ID
- 22226018
Pubmed Central ID
- 22226018
Electronic International Standard Serial Number (EISSN)
- 1873-5835
Digital Object Identifier (DOI)
- 10.1016/j.leukres.2011.12.010
Language
- eng
Conference Location
- England